[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344833-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344833-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","age-and-sex-based-differences-in-the-genomic-profiles-of-patients-with-gastrointestinal-and-pancreatic-neuroendocrine-neoplasms","Age and sex-based differences in the genomic profiles of patients with gastrointestinal and pancreatic neuroendocrine neoplasms","","Purpose: Age and sex are known to influence outcomes in neuroendocrine neoplasms (NENs), yet their molecular determinants remain poorly defined. We analyzed a real-world dataset of gastrointestinal (GI) and pancreatic (P) NENs to define clinical, molecular, and immune profiles. Methods: 1935 cases were assessed by Next Generation/Whole Exome Sequencing, and 1211 cases additionally by Whole Transcriptome Sequencing, comparing molecular and immune features by age and sex. Results: Older age and sex-specific mutation and immune patterns were observed, with hypothesis-generating implications for future validation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/age-and-sex-based-differences-in-the-genomic-profiles-of-patients-with-gastrointestinal-and-pancreatic-neuroendocrine-neoplasms/344833/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/age-and-sex-based-differences-in-the-genomic-profiles-of-patients-with-gastrointestinal-and-pancreatic-neuroendocrine-neoplasms/344833.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does age affect survival in gastrointestinal and pancreatic neuroendocrine neoplasms?","Question",{"text":63,"@type":64},"Older age at diagnosis was associated with worse survival in both gastrointestinal and pancreatic NENs, according to the results.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which molecular mutations and immune checkpoint genes change with increasing age in GI-NENs?",{"text":68,"@type":64},"In GI-NENs, TP53, RB1, FAT1, and KMT2D mutations increased with age, alongside increased expression of LAG3, CD80, and HAVCR2, while APC mutations and M2 macrophages decreased.",{"name":70,"@type":61,"acceptedAnswer":71},"What sex-associated genomic differences were observed between GI-NENs and P-NENs?",{"text":72,"@type":64},"For GI-NENs, TP53, FBXW7, and TERT promoter mutations and genomic loss of heterozygosity increased in males. For P-NENs, PIK3CA mutations and dMMR/MSI-H increased in females.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344833,1790573888,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":118,"preview_page_count":33,"preview_urls":145},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Age-and sex-based differences in the genomic profiles of patients with gastrointestinal and pancreatic neuroendocrine neoplasms  \nShuning Li1, Lisa Liu1, Nishant Gandhi2, Alex Farrell2, Emil Lou3,, Heloisa Soares4, Bassel Nazha5, Jeffrey Swensen2, Matthew Oberley2,, Mark G. Evans2, Pamela Kunz6, Namrata Vijayvergia*, 1,  \n1Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, United States 2Caris Life Sciences, Phoenix, AZ 85040, United States  \n3Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States 4 Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, United States 5Winship Cancer Institute, Emory University, Atlanta, GA 30322, United States  \n6Smilow Cancer Hospital/Yale Cancer Center, Yale University, North Haven, CT 06510, United States  \nCorresponding author: Namrata Vijayvergia, MD, Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA ([namrata.vijayvergia@fccc.edu](namrata.vijayvergia@fccc.edu)) .  \nAbstract  \nPurpose: Age and sex are known to influence outcomes in neuroendocrine neoplasms (NENs), yet their molecular determinants remain poorly defined. We queried a real-world dataset of gastrointestinal (GI) tract and pancreatic (P) NENs and characterized their clinical, molecular, and immune profiles.  \nMethods: One thousand nine hundred thirty-five cases (GI: n = 1431, P: n = 504) of NENs were analyzed using Next Generation or Whole Exome Sequencing of DNA, and 1211/1935 cases (GI: n = 917, P: n = 294) underwent Whole Transcriptome Sequencing. We compared the molecular and immune profile with respect to age and sex.  \nResults: Older age at diagnosis was associated with worse survival in both GI- and P-NENs. In patients with GI-NENs, there was decreased survival in males compared to females. In GI-NENs, TP53, RB1, FAT1, and KMT2D mutations, as well as immune checkpoint gene (ICG) expressions of LAG3, CD80, and HAVCR2 and M1 macrophages increased with increasing age while APC mutations and M2 macrophages decreased with increasing age. In P-NENs, TP53, RB1, KRAS, and SMAD4 mutations and CD4+ T cells increased with increasing age while MUTYH and NTHL1 mutations and M2 macrophages decreased with increasing age. In GI-NENs, TP53, FBXW7, and TERT (promoter) mutations and genomic loss of heterozygosity (gLOH) were increased in males. In P-NENs, PIK3CA mutations and dMMR/MSI-H were increased in females. Conclusion: Our study queries one of the largest datasets of GI-and P-NENs to date and highlights distinct age-and sex-specific molecular and immune profiles. Given the exploratory nature of these analyses and borderline significance, these results remain hypothesis-generating, providing an initial framework for future validation studies.  \nKey words: neuroendocrine neoplasms; GI-NEN; P-NEN; molecular profiling; immune landscape; sex differences; age stratification.  \nImplications for Practice  \nDemographic factors such as age and sex are associated with different outcomes in patients with NENs, yet little is known about the molecular basis underlying these differences. This study offers the most comprehensive real-world analysis of GI-and P-NENs to date, revealing age-and sex-associated differences in tumor mutations, immune checkpoint gene expression, and immune cell infiltration. These findings are hypothesis-generating and highlight the need to incorporate demographic stratification in clinical trial design and treatment planning. Ultimately, this work provides a foundation for more tailored treatment approaches for patients with NENs.  \nIntroduction  \nNeuroendocrine neoplasms (NENs) arise throughout the body and encompass a heterogeneous group of diseases across a full spectrum of potential clinical behavior, from indolent andasymptomatic to more aggressive and highly symptomatic in nature. A small portion of NENs is associated with familial syndromes like multiple endocrine neoplasia type 1 (","cbCain4FowqEnXmt","https://ap.wps.com/l/cbCain4FowqEnXmt","pdf",2356183,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Implications for Practice\n# Introduction","[{\"question\":\"How does age affect survival in gastrointestinal and pancreatic neuroendocrine neoplasms?\",\"answer\":\"Older age at diagnosis was associated with worse survival in both gastrointestinal and pancreatic NENs, according to the results.\"},{\"question\":\"Which molecular mutations and immune checkpoint genes change with increasing age in GI-NENs?\",\"answer\":\"In GI-NENs, TP53, RB1, FAT1, and KMT2D mutations increased with age, alongside increased expression of LAG3, CD80, and HAVCR2, while APC mutations and M2 macrophages decreased.\"},{\"question\":\"What sex-associated genomic differences were observed between GI-NENs and P-NENs?\",\"answer\":\"For GI-NENs, TP53, FBXW7, and TERT promoter mutations and genomic loss of heterozygosity increased in males. For P-NENs, PIK3CA mutations and dMMR/MSI-H increased in females.\"}]","Age and sex-based differences in the genomic profiles of patients with gastrointestinal and pancreatic neuroendocrine neoplasms | PDF",1790055402,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34691db7dfc725a6e747cdafc81db3a7.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23be48d5c6ec4e31f1b2157709b14891.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a24c7ac4e38abf860d0131fba36f4744.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6f2016038cc37d0bd2af3c3f4728e1d.webp",980,1287]